Journey Medical (DERM) Shares Outstanding (2020 - 2026)

Journey Medical (DERM) has reported Shares Outstanding (Entity) for 7 consecutive years, with $27.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 18.05% year-over-year to $27.5 million; the trailing twelve-month figure through Jun 2026 stood at $27.5 million (up 18.05% YoY), and the FY2025 full-year result was $21.1 million, up 3.49% from the prior year.
• Shares Outstanding (Entity) rose to $27.5 million in Q2 2026 per DERM's latest filing, from $27.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $27.5 million in Q2 2026 and bottomed at $17.3 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $20.3 million across 5 years, with a median of $19.9 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) soared 92.31% in 2022, then slipped 0.8% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $17.5 million in 2022, then gained by 4.0% to $18.2 million in 2023, then rose by 12.06% to $20.4 million in 2024, then rose by 3.49% to $21.1 million in 2025, then soared by 30.03% to $27.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $27.5 million, $27.3 million, and $21.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.